1.
Carretta C, Rontauroli S, Bertesi M, Parenti S, Maccaferri M, Benati D, Malerba M, Neroni A, Papa E, Norfo R, Mirabile M, Tavernari L, Tombari C, Guglielmelli P, Recchia A, Potenza L, Tagliafico E, Luppi M, Vannucchi A, Manfredini R. CO58 | Single-cell multi-omics unravels molecular and cellular programs underlying ruxolitinib response in myelofibrosis: C. Carretta1|2, S. Rontauroli1|2, M. Bertesi1|3, S. Parenti1|2, M. Maccaferri4, D. Benati1|3, M. Malerba1|3, A. Neroni1|3, E. Papa1|3, R. Norfo1|2, M. Mirabile1|3, L. Tavernari1|2, C. Tombari1|2, P. Guglielmelli5|6, A. Recchia1|3, L. Potenza4|7, E. Tagliafico7|8, M. Luppi4|7, A. Vannucchi5|6, R. Manfredini1|2 | 1Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia; 3Department of Life Sciences, University of Modena and Reggio Emilia; 4Department Oncology and Hematology, Hematology Unit, Modena University Hospital; 5CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence; 6Department of Experimental and Clinical Medicine, University of Florence; 7Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 8Department of Laboratory Medicine, Diagnostic Hematology and Clinical Genomics Unit, Modena University Hospital. Haematologica 2026; 111(s1); https://doi.org/10.3324/haematol.2026.s1.61.